Skip to content
2000
Volume 26, Issue 14
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Introduction

The macrolide-resistant (MRBp) has appeared in Asia and has even been prevalent in China. Since the antibiotic sensitivity test is not carried out in the clinical setting, macrolide is still the first choice of antibiotic in MRBp infection. Further, the macrolide therapy for pertussis needs to be revised. Macrolide has always shown a positive effect on other macrolide-resistant bacterium infections in clinical applications. However, the mechanism of macrolide on MRBp remains unclear.

Objective

The objective of this study was to investigate the effect of virulence of MRBp under the sub-MIC erythromycin.

Methods

This study evaluated a representative isolate BP19147 (/-MRBp) under a series of sub-inhibitory concentrations of erythromycin. We measured the growth curve, biofilm formation, and autoaggregation assay under Stainer and Scholte (SS) broth. The relative gene expression was detected by RT-qPCR.

Results

The proteomics was detected by label-fee DIA. The growth ability and virulence factors of MR isolate BP19147 were inhibited by sub-MIC of erythromycin and had a concentration-dependent effect. From the proteomics results, the pertussis toxin, filamentous haemagglutinin, and pertactin did not show a statistical difference ( >0.05). Other virulence factors (including dermonecrotic toxin, Invasive Adenylate cyclase/haemolysin. ) showed a statistical difference ( <0.05). In the KEGG enrichment, the BvgAS system, biofilm formation, and some adaptive systems were inhibited by erythromycin.

Conclusion

The sub-MIC of erythromycin may reduce the virulence of MRBp, which will provide a theoretical basis for the rational use of erythromycin for MRBp infection and help the development of new antibiotics.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010320349240905052242
2024-09-20
2025-12-18
Loading full text...

Full text loading...

References

  1. WangZ. CuiZ. LiY. HouT. LiuX. XiY. LiuY. LiH. HeQ. High prevalence of erythromycin-resistant Bordetella pertussis in Xi’an, China.Clin. Microbiol. Infect.20142011O825O83010.1111/1469‑0691.12671 24816168
    [Google Scholar]
  2. WuX. DuQ. LiD. YuanL. MengQ. FuZ. XuH. YaoK. ZhaoR. A cross-sectional study revealing the emergence of erythromycin-resistant bordetella pertussis carrying ptxp3 alleles in China.Front. Microbiol.20221390161710.3389/fmicb.2022.901617 35923401
    [Google Scholar]
  3. ZhangQ. ZhengH. LiuM. HanK. ShuJ. WuC. XuN. HeQ. LuoH. The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: A cross sectional study.BMC Infect. Dis.201212113810.1186/1471‑2334‑12‑138 22892100
    [Google Scholar]
  4. TiwariT. MurphyT.V. MoranJ. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines.MMWR Recomm. Rep.20055414116 16340941
    [Google Scholar]
  5. MiY.M. HuaC.Z. FangC. LiuJ.J. XieY.P. LinL.N. WangG.L. Effect of macrolides and β-lactams on clearance of bordetella pertussis in the nasopharynx in children with whooping cough.Pediatr. Infect. Dis. J.2021402879010.1097/INF.0000000000002911 33021592
    [Google Scholar]
  6. OttoM.P. MartinE. BadiouC. LebrunS. BesM. VandeneschF. EtienneJ. LinaG. DumitrescuO. Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus.J. Antimicrob. Chemother.20136871524153210.1093/jac/dkt073 23508621
    [Google Scholar]
  7. HoriiT. MoritaM. MuramatsuH. MuranakaY. KannoT. MaekawaM. Effects of mupirocin at subinhibitory concentrations on flagella formation in Pseudomonas aeruginosa and Proteus mirabilis.J. Antimicrob. Chemother.20035151175117910.1093/jac/dkg226 12697640
    [Google Scholar]
  8. LvZ. YinS. JiangK. WangW. LuanY. WuS. ShiJ. LiZ. MaX. WangZ. YanH. The whole-cell proteome shows the characteristics of macrolides-resistant Bordetella pertussis in China linked to the biofilm formation.Arch. Microbiol.2023205621910.1007/s00203‑023‑03566‑0 37148370
    [Google Scholar]
  9. KarimiF. HamidianY. BehrouzifarF. MostafazadehR. Ghorbani-HasanSaraei, A.; Alizadeh, M.; Mortazavi, S.M.; Janbazi, M.; Naderi Asrami, P. An applicable method for extraction of whole seeds protein and its determination through Bradford’s method.Food Chem. Toxicol.202216411305310.1016/j.fct.2022.113053 35460823
    [Google Scholar]
  10. ZarogoulidisP. PapanasN. KioumisI. ChatzakiE. MaltezosE. ZarogoulidisK. Macrolides: From in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Eur. J. Clin. Pharmacol.201268547950310.1007/s00228‑011‑1161‑x 22105373
    [Google Scholar]
  11. FokkensW.J. LundV.J. MullolJ. BachertC. AlobidI. BaroodyF. CohenN. CervinA. DouglasR. GevaertP. GeorgalasC. GoossensH. HarveyR. HellingsP. HopkinsC. JonesN. JoosG. KalogjeraL. KernB. KowalskiM. PriceD. RiechelmannH. SchlosserR. SeniorB. ThomasM. ToskalaE. VoegelsR. European position paper on rhinosinusitis and Nasal polyps.Rhinol Suppl.201223>31298
    [Google Scholar]
  12. YasudaH. AjikiY. KogaT. KawadaH. YokotaT. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.Antimicrob. Agents Chemother.19933791749175510.1128/AAC.37.9.1749 8239580
    [Google Scholar]
  13. HerrouJ. BompardC. WintjensR. DupréE. WilleryE. VilleretV. LochtC. AntoineR. Jacob-DubuissonF. Periplasmic domain of the sensor-kinase BvgS reveals a new paradigm for the Venus flytrap mechanism.Proc. Natl. Acad. Sci.201010740173511735510.1073/pnas.1006267107 20855615
    [Google Scholar]
  14. MerkelT.J. BarrosC. StibitzS. Characterization of the bvgR Locus of Bordetella pertussis.J. Bacteriol.199818071682169010.1128/JB.180.7.1682‑1690.1998 9537363
    [Google Scholar]
  15. YahalomA. ShakedH. RuthsteinS. ChillJ.H. Inherent minor conformer of Bordetella effector btea directs chaperone-mediated unfolding.J. Am. Chem. Soc.202214426115531155710.1021/jacs.2c04122 35749268
    [Google Scholar]
  16. Fernandez-BrandoR.J. YamaguchiN. TahounA. McAteerS.P. GillespieT. WangD. ArgyleS.A. PalermoM.S. GallyD.L. Type III secretion-dependent sensitivity of escherichia coli o157 to specific ketolides.Antimicrob. Agents Chemother.201660145947010.1128/AAC.02085‑15 26525795
    [Google Scholar]
  17. TantisuwannoC. DangF. BenderK. SpencerJ.D. JenningsM.E. BartonH.A. JoyA. Synergism between Rifampicin and Cationic Polyurethanes overcomes intrinsic resistance of Escherichia coli.Biomacromolecules20212272910292010.1021/acs.biomac.1c00306 34085824
    [Google Scholar]
  18. Pomares AmigóX. Monton SolerC. Espasa SoleyM. Casabon SalasJ. MonsóE. Gallego DiazM. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.Int. J. Chron. Obstruct. Pulmon. Dis.2011644945610.2147/COPD.S23655 22003290
    [Google Scholar]
  19. SuyamaH. LuuL.D. ZhongL. RafteryM.J. LanR. Integrating proteomic data with metabolic modeling provides insight into key pathways of Bordetella pertussis biofilms.Front. Microbiol.202314116987010.3389/fmicb.2023.1169870 37601354
    [Google Scholar]
  20. RomeroD. TraxlerM.F. LópezD. KolterR. Antibiotics as signal molecules.Chem. Rev.201111195492550510.1021/cr2000509 21786783
    [Google Scholar]
  21. Muñoz-ElíasE.J. McKinneyJ.D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.Nat. Med.200511663864410.1038/nm1252 15895072
    [Google Scholar]
  22. BhusalR.P. JiaoW. KwaiB.X. ReynissonJ. CollinsA.J. SperryJ. BashiriG. LeungI.K. Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2.Nat. Commun.2019101463910.1038/s41467‑019‑12614‑7 31604954
    [Google Scholar]
  23. CohenH. AdaniB. CohenE. PisconB. AzrielS. DesaiP. BähreH. McClellandM. RahavG. Gal-MorO. The ancestral stringent response potentiator, DksA has been adapted throughout Salmonella evolution to orchestrate the expression of metabolic, motility, and virulence pathways.Gut Microbes2022141199729410.1080/19490976.2021.1997294 34923900
    [Google Scholar]
/content/journals/cpb/10.2174/0113892010320349240905052242
Loading
/content/journals/cpb/10.2174/0113892010320349240905052242
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test